SU672189A1 - 2-Хлор-6-метил-4-арилалкилфенолы, про вл ющие антимикробную активность - Google Patents
2-Хлор-6-метил-4-арилалкилфенолы, про вл ющие антимикробную активностьInfo
- Publication number
- SU672189A1 SU672189A1 SU772460620A SU2460620A SU672189A1 SU 672189 A1 SU672189 A1 SU 672189A1 SU 772460620 A SU772460620 A SU 772460620A SU 2460620 A SU2460620 A SU 2460620A SU 672189 A1 SU672189 A1 SU 672189A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- chloro
- activity
- reaction
- methyl
- hmf
- Prior art date
Links
- 230000000845 anti-microbial effect Effects 0.000 title 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000004094 surface-active agent Substances 0.000 description 11
- 239000000344 soap Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 8
- 230000001557 mycostatic effect Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- QFVAWNPSRQWSDU-UHFFFAOYSA-N Dibenzthion Chemical compound C1N(CC=2C=CC=CC=2)C(=S)SCN1CC1=CC=CC=C1 QFVAWNPSRQWSDU-UHFFFAOYSA-N 0.000 description 7
- 239000002674 ointment Substances 0.000 description 7
- 229960002999 sulbentine Drugs 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 230000003385 bacteriostatic effect Effects 0.000 description 6
- 230000001235 sensitizing effect Effects 0.000 description 6
- YPNZJHFXFVLXSE-UHFFFAOYSA-N 2-chloro-6-methylphenol Chemical compound CC1=CC=CC(Cl)=C1O YPNZJHFXFVLXSE-UHFFFAOYSA-N 0.000 description 5
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 5
- 229960004011 methenamine Drugs 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 241000700198 Cavia Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 4
- 229910021538 borax Inorganic materials 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 4
- 229960000349 nitrofural Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 235000010339 sodium tetraborate Nutrition 0.000 description 4
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 206010007134 Candida infections Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 201000003984 candidiasis Diseases 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000004312 hexamethylene tetramine Substances 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 3
- 229960002447 thiram Drugs 0.000 description 3
- XQACWEBGSZBLRG-UHFFFAOYSA-N 1-bromo-4-isothiocyanatobenzene Chemical compound BrC1=CC=C(N=C=S)C=C1 XQACWEBGSZBLRG-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 2
- 229940073608 benzyl chloride Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 238000011968 cross flow microfiltration Methods 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002541 mycostatic Substances 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- -1 zinc or titanium Chemical class 0.000 description 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- VUTBELPREDJDDH-UHFFFAOYSA-N 4-amino-5-hydroxymethyl-2-methylpyrimidine Chemical compound CC1=NC=C(CO)C(N)=N1 VUTBELPREDJDDH-UHFFFAOYSA-N 0.000 description 1
- ZNNPQQQAYCQFHP-UHFFFAOYSA-N 4-benzyl-2-chloro-6-methylphenol Chemical compound ClC1=C(O)C(C)=CC(CC=2C=CC=CC=2)=C1 ZNNPQQQAYCQFHP-UHFFFAOYSA-N 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- SLIOTAXNLZYTAR-UHFFFAOYSA-N C=CC1=CC=CC=C1.C(C1=CC=CC=C1)Cl Chemical compound C=CC1=CC=CC=C1.C(C1=CC=CC=C1)Cl SLIOTAXNLZYTAR-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- 241000223233 Cutaneotrichosporon cutaneum Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010051602 Laziness Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/367—Halogenated derivatives polycyclic non-condensed, containing only six-membered aromatic rings as cyclic parts, e.g. halogenated poly-hydroxyphenylalkanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD7600191842A DD131746A1 (de) | 1976-03-15 | 1976-03-15 | Verfahren zur herstellung antimikrobiell wirksamer,epidermal vertraeglicher verbindungen aus abfaellen der 4-chlor-2-methylphenol-synthese |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU672189A1 true SU672189A1 (ru) | 1979-07-05 |
Family
ID=5503919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU772460620A SU672189A1 (ru) | 1976-03-15 | 1977-03-11 | 2-Хлор-6-метил-4-арилалкилфенолы, про вл ющие антимикробную активность |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS52144659A (fr) |
| AT (1) | AT346320B (fr) |
| BE (1) | BE852389A (fr) |
| CH (1) | CH629169A5 (fr) |
| DD (1) | DD131746A1 (fr) |
| DE (1) | DE2706747C2 (fr) |
| DK (1) | DK147621C (fr) |
| FI (1) | FI65772C (fr) |
| GB (1) | GB1509520A (fr) |
| IT (1) | IT1115841B (fr) |
| NL (1) | NL7702773A (fr) |
| SE (1) | SE441671B (fr) |
| SU (1) | SU672189A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2549543C2 (ru) * | 2010-12-21 | 2015-04-27 | Колгейт-Палмолив Компани | Галогенированные бифенолы в качестве антибактериальных средств |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI68498C (fi) * | 1981-06-25 | 1985-10-10 | Web Berlin Chemie | Blandning foer bekaempning av fytopatogeniska svampar och bakterier |
| YU110082A (en) * | 1981-07-08 | 1985-03-20 | Jenapharm Veb | Process for obtaining phenol derivatives of antimicrobial activity |
| GB2154879A (en) * | 1984-02-29 | 1985-09-18 | Coalite Group Plc | Foliage desiccant or defoliant |
| EP0155783A1 (fr) * | 1984-02-29 | 1985-09-25 | Coalite Group Plc | Dessiccatif de feuillage ou agent de défoliation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2077780B1 (fr) * | 1970-02-13 | 1973-03-16 | Inst Rech Chim Biolog |
-
1976
- 1976-03-15 DD DD7600191842A patent/DD131746A1/xx unknown
-
1977
- 1977-02-17 DE DE2706747A patent/DE2706747C2/de not_active Expired
- 1977-03-08 GB GB9710/77A patent/GB1509520A/en not_active Expired
- 1977-03-09 IT IT48389/77A patent/IT1115841B/it active
- 1977-03-11 BE BE175729A patent/BE852389A/fr not_active IP Right Cessation
- 1977-03-11 SU SU772460620A patent/SU672189A1/ru active
- 1977-03-14 SE SE7702880A patent/SE441671B/xx not_active IP Right Cessation
- 1977-03-14 DK DK108577A patent/DK147621C/da not_active IP Right Cessation
- 1977-03-15 AT AT174877A patent/AT346320B/de not_active IP Right Cessation
- 1977-03-15 JP JP2852777A patent/JPS52144659A/ja active Pending
- 1977-03-15 CH CH320977A patent/CH629169A5/de not_active IP Right Cessation
- 1977-03-15 NL NL7702773A patent/NL7702773A/xx not_active Application Discontinuation
- 1977-03-15 FI FI770825A patent/FI65772C/fi not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2549543C2 (ru) * | 2010-12-21 | 2015-04-27 | Колгейт-Палмолив Компани | Галогенированные бифенолы в качестве антибактериальных средств |
Also Published As
| Publication number | Publication date |
|---|---|
| DK147621B (da) | 1984-10-22 |
| DK108577A (da) | 1977-09-16 |
| AT346320B (de) | 1978-11-10 |
| DE2706747C2 (de) | 1982-07-01 |
| DD131746A1 (de) | 1978-07-19 |
| FI770825A7 (fr) | 1977-09-16 |
| DK147621C (da) | 1985-07-22 |
| FI65772B (fi) | 1984-03-30 |
| DE2706747A1 (de) | 1977-09-22 |
| JPS52144659A (en) | 1977-12-02 |
| NL7702773A (nl) | 1977-09-19 |
| GB1509520A (en) | 1978-05-04 |
| SE441671B (sv) | 1985-10-28 |
| CH629169A5 (en) | 1982-04-15 |
| ATA174877A (de) | 1978-03-15 |
| BE852389A (fr) | 1977-09-12 |
| FI65772C (fi) | 1984-07-10 |
| IT1115841B (it) | 1986-02-10 |
| SE7702880L (sv) | 1977-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK175632B1 (da) | Tofaseoplösningsmiddelbærersystem | |
| US2295505A (en) | Composition of matter | |
| JPS59134726A (ja) | 低誘電溶媒を含有する貯蔵安定な局所薬剤組成物 | |
| US2731386A (en) | Antifungal composition | |
| CN111836877A (zh) | 抗菌防腐剂组合物 | |
| RU2423131C2 (ru) | Средство для лечения заболеваний в ветеринарии на основе соли фосфония | |
| US20070122464A1 (en) | Use of osmolytes obtained from extremophilic bacteria for producing medicine for the external treatment of neurodermatitis | |
| SU672189A1 (ru) | 2-Хлор-6-метил-4-арилалкилфенолы, про вл ющие антимикробную активность | |
| US3265571A (en) | Thixotropic acne vulgaris composition | |
| US3065133A (en) | Imidazoles for the control of histomoniasis | |
| CA2383357C (fr) | Utilisation de tosylchloramide(s) pour le traitement de maladies de la peau, de la muqueuse, d'organes et de tissus | |
| US3751565A (en) | Therapeutic compositions | |
| WO2013102234A1 (fr) | Formulation et procédé pour le traitement de la douleur et/ou de l'inflammation associées à une affection de la peau | |
| JPS6210223B2 (fr) | ||
| US20140348939A1 (en) | Wound care product with egg shell membrane | |
| JP7780095B2 (ja) | ヒト用抗真菌剤 | |
| EP3313369B1 (fr) | Composition émolliente | |
| JPH0132805B2 (fr) | ||
| RU2788332C1 (ru) | Мазь для лечения травматического повреждения кожных покровов | |
| RU2058141C1 (ru) | Фунгицидный состав | |
| RU2737268C1 (ru) | Косметическая и/или фармацевтическая композиция для лечения заболеваний кожного покрова | |
| RU2824808C1 (ru) | Способ лечения конъюнктивита у крупного рогатого скота | |
| RU2563811C1 (ru) | Фармацевтическая композиция для лечения грибковых заболеваний | |
| KR860001000B1 (ko) | N,N"-비스(4-클로로페닐)-3,12-디이미노-2,4,11,13-테트라아자-테트라데칸-디이미도아미드의 (+)-6-메톡시-α-메틸-2-나프탈렌아세테이트화합물의 제조방법 | |
| JPS6229521A (ja) | 浅在性真菌症の治療剤 |